TY  - JOUR
AU  - Rondy, Marc
AU  - Kissling, Esther
AU  - Emborg, Hanne-Dorthe
AU  - Gherasim, Alin Manuel
AU  - Pebody, Richard
AU  - Trebbien, Ramona
AU  - Pozo Sanchez, Francisco
AU  - Larrauri, Amparo
AU  - McMenamin, Jim
AU  - Valenciano, Marta
AU  - I-MOVE/I-MOVE+ group
AU  - Delgado-Sanz, Concepcion
AU  - Oliva Dominguez, Jesus Angel
AU  - Casas Flecha, Inmaculada
PY  - 2018
DO  - 10.2807/1560-7917.ES.2018.23.9.18-00086
SN  - 1560-7917
UR  - http://hdl.handle.net/20.500.12105/8992
AB  - Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age...
LA  - eng
PB  - European Centre for Disease Prevention and Control (ECDC)
KW  - Europe
KW  - Case control study
KW  - Influenza
KW  - Influenza vaccination
KW  - Influenza vaccine effectiveness
KW  - Multicentre study
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Child
KW  - Child, Preschool
KW  - Europe
KW  - European Union
KW  - Female
KW  - Humans
KW  - Infant
KW  - Infant, Newborn
KW  - Influenza A Virus, H1N1 Subtype
KW  - Influenza A Virus, H3N2 Subtype
KW  - Influenza B virus
KW  - Influenza Vaccines
KW  - Influenza, Human
KW  - Male
KW  - Middle Aged
KW  - Pandemics
KW  - Treatment Outcome
KW  - Vaccination
KW  - Seasons
TI  - Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
TY  - journal article
ER  -